By Bachem AG
To get in touch with Bachem AG, simply fill out the form below.
Subscribe to Supplier
Bachem brings new small molecule and generic peptide API offers to CPhI Japan
Bubendorf, Switzerland: –Peptide and Oligonucleotide technology specialist Bachem AG is again be a prominent presence at Asia’s premier pharma trade expo, CPhI Japan in Tokyo.
Under its ‘Leading Partner in Tides’ banner, the Bachem stand at Booth B-38 at Tokyo’s Big Sight Exhibition Center will showcase its ever-expanding portfolio of CMO capabilities in peptide-based active pharmaceutical ingredients (APIs), their record of over 80 DMF filings and how Bachem can support the success of client projects from initiation, through all clinical development phases to commercial supply.
Small molecule and generic peptide APIs
For 2021, the Bachem display will focus on its innovative range of small molecule and generic peptide APIs and proprietary processes that harness its outstanding knowledge of peptides, now expanding into oligonucleotides.
The Bachem team in Tokyo will include Dr. Satoshi Mashiko, Head of Business Development, for Tokyo-based Bachem K.K.
Expanding peptide market
Bachem has a close relationship with CPhI Japan, having attended the event every year since 2016.
It sees CPhI as a ‘must attend’ since peptides are a core part of its business and the Asian market, with Japan in particular, has become ever more important to the sector.
It will be reaching out to key suppliers and buyers for peptide generic APIs and small molecule generic APIs to present its advanced manufacturing cGMP multi-tons capabilities in Switzerland and the USA, based on close to 50 Years’ experience in peptide chemistry.
Bachem will also feature its comprehensive Technical and Regulatory Support, with 80 DMF drug master files and CEP suitability certificates filed.
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Under its banner Leading Partner in Tides, Bachem prioritizes continuous investment in R&D on chemistries and technologies as crucial for future success. Its ever-increasing knowledge of complex proteins and peptides derives from ongoing research in proteomics, as well as progress in mass spectrometry, synthesis and ligation technologies, complemented by collaboration with external research institutions.
Bachem has five production sites in the US, UK and Switzerland along with research level production and full cGMP manufacturing facilities on both continents. These provide capacity to produce APIs, key intermediates, small molecule generics, and new chemical entities (NCEs) at preclinical, clinical and production scales.
Further information at: www.bachem.com
About CPhI Japan 2021
The COVID-19 coronavirus pandemic has effectively expanded the scope and reach of CPhI Japan, which was already one of the most prestigious events on the global pharma industry calendar as one of the family of high profile pharma trade shows created by UBM Live.
CPhI Japan 2021 will be a three-day physical event opening April 14 at Tokyo’s Big Sight Exhibition Center. However, to recognise COVID priorities, this will now be accompanied by a virtual edition, CPhI Japan Connect, hosted online over a full month, opening March 30.
As before, both the physical and virtual events will incorporate the CPhI expo and six other zoned exhibitions: ICSE for outsourcing solutions, P-MEC (including LabWorld) for machinery and equipment, bioLIVE for biopharma developments, InnoPack for delivery systems and packing, FDF for finished dosage products, and NEX for natural extracts.
The event is organized by Informa and UBM Japan with further information at: https://www.cphi.com/japan/en/home.html